Royal Bank of Canada’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23K | Sell |
1,079
-550
| -34% | -$10.2K | ﹤0.01% | 5846 |
|
|
2025
Q4 | $22K | Sell |
1,629
-34,545
| -95% | -$538K | ﹤0.01% | 5990 |
|
|
2025
Q3 | $640K | Buy |
36,174
+16,836
| +87% | +$266K | ﹤0.01% | 4298 |
|
|
2025
Q2 | $292K | Buy |
19,338
+18,092
| +1,452% | +$300K | ﹤0.01% | 4881 |
|
|
2025
Q1 | $20K | Sell |
1,246
-533
| -30% | -$9.94K | ﹤0.01% | 5930 |
|
|
2024
Q4 | $31K | Sell |
1,779
-1,296
| -42% | -$22.8K | ﹤0.01% | 5915 |
|
|
2024
Q3 | $54K | Buy |
3,075
+283
| +10% | +$4.83K | ﹤0.01% | 5661 |
|
|
2024
Q2 | $31K | Buy |
2,792
+1,359
| +95% | +$12.8K | ﹤0.01% | 5874 |
|
|
2024
Q1 | $12K | Sell |
1,433
-13,219
| -90% | -$122K | ﹤0.01% | 6136 |
|
|
2023
Q4 | $179K | Buy |
14,652
+8,098
| +124% | +$56.1K | ﹤0.01% | 5194 |
|
|
2023
Q3 | $26K | Buy |
6,554
+3,418
| +109% | +$21.2K | ﹤0.01% | 6088 |
|
|
2023
Q2 | $23K | Sell |
3,136
-1,431
| -31% | -$9.14K | ﹤0.01% | 6146 |
|
|
2023
Q1 | $15K | Buy |
4,567
+3,732
| +447% | +$11.3K | ﹤0.01% | 6145 |
|
|
2022
Q4 | $2K | Buy |
835
+733
| +719% | +$1.65K | ﹤0.01% | 6942 |
|
|
2022
Q3 | $0 | Buy |
102
+2
| +2% | +$3 | ﹤0.01% | 7752 |
|
|
2022
Q2 | $0 | Sell |
100
-942
| -90% | -$2.37K | ﹤0.01% | 7632 |
|
|
2022
Q1 | $5K | Sell |
1,042
-2,320
| -69% | -$19K | ﹤0.01% | 7264 |
|
|
2021
Q4 | $50K | Buy |
3,362
+1,038
| +45% | +$20.7K | ﹤0.01% | 6371 |
|
|
2021
Q3 | $50K | Buy |
2,324
+701
| +43% | +$15.1K | ﹤0.01% | 6164 |
|
|
2021
Q2 | $27K | Sell |
1,623
-323
| -17% | -$6.15K | ﹤0.01% | 6402 |
|
|
2021
Q1 | $46K | Buy |
1,946
+909
| +88% | +$27.2K | ﹤0.01% | 5937 |
|
|
2020
Q4 | $25K | Buy |
1,037
+925
| +826% | +$14.7K | ﹤0.01% | 5961 |
|
|
2020
Q3 | $1K | Sell |
112
-1
| -0.9% | -$11 | ﹤0.01% | 6465 |
|
|
2020
Q2 | $1K | Sell |
113
-227
| -67% | -$2.04K | ﹤0.01% | 6468 |
|
|
2020
Q1 | $2K | Sell |
340
-1,057
| -76% | -$11K | ﹤0.01% | 6318 |
|
|
2019
Q4 | $18K | Buy |
1,397
+840
| +151% | +$12K | ﹤0.01% | 5904 |
|
|
2019
Q3 | $9K | Buy |
+557
| New | +$7.23K | ﹤0.01% | 5816 |
|
|
2018
Q4 | – | Sell |
-165
| Closed | -$2K | – | 7024 |
|
|
2018
Q3 | $2K | Buy |
+165
| New | +$2.34K | ﹤0.01% | 6530 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$1K | – | 6703 |
|
|
2018
Q1 | $1K | Sell |
100
-96
| -49% | -$1.82K | ﹤0.01% | 6217 |
|
|
2017
Q4 | $4K | Sell |
196
-700
| -78% | -$16.5K | ﹤0.01% | 6134 |
|
|
2017
Q3 | $17K | Buy |
896
+784
| +700% | +$17.8K | ﹤0.01% | 6035 |
|
|
2017
Q2 | $3K | Buy |
112
+12
| +12% | +$330 | ﹤0.01% | 6198 |
|
|
2017
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 6433 |
|
|
2016
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 6562 |
|
|
2016
Q3 | $1K | Buy |
+100
| New | +$510 | ﹤0.01% | 6298 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
Royal Bank of Canada's PLSE Position: Q1 2026 in Review
Royal Bank of Canada reduced its Pulse Biosciences (PLSE) stake by 34% in Q1 2026, selling an estimated $10.2K and leaving 1,079 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #5846.
Royal Bank of Canada first reported a position in PLSE in Q3 2016 and has held it in 35 quarters since. The position peaked at $640K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- Royal Bank of Canada held 1,079 shares of Pulse Biosciences worth $23K as of Q1 2026.
- Royal Bank of Canada sold 550 Pulse Biosciences shares in Q1 2026, an estimated $10.2K.
- Pulse Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5846 holding.
- Royal Bank of Canada first reported a position in Pulse Biosciences in Q3 2016 and has held it in 35 quarters since.
- Royal Bank of Canada's Pulse Biosciences position peaked at $640K in Q3 2025.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.